claim
Posted by will
•
January 27, 2026 at 09:03 AM
Prioritizing safety and informed consent is critical; the potential risks of puberty blockers should not be downplayed in the Pathways trial.
Vote to see results
Responses & Discussion
Log in to add your response to this statement
Log InNo responses yet. Be the first to share your perspective!